Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m (NCT00136604) | GlaxoSmithKline | 2006-01-22 |
| Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children (NCT00228917) | GlaxoSmithKline | 2005-06-16 |
Track Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin automatically
Every clearance here is in the API, with alerts when new ones post.